TSX-V:NDVA - TSX Venture Exchange - CA45580J1012 - Common Stock - Currency: CAD
TSX-V:NDVA (6/12/2024, 7:00:00 PM)
0.03
-0.01 (-14.29%)
The current stock price of NDVA.CA is 0.03 CAD. In the past month the price decreased by -53.85%.
Symbol | Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
BHC.CA | BAUSCH HEALTH COS INC | 1.44 | 2.78B | ||
CRON.CA | CRONOS GROUP INC | 17.86 | 963.52M | ||
TLRY.CA | TILRAY BRANDS INC | N/A | 684.42M | ||
DHT-UN.CA | DRI HEALTHCARE TRUST | 5.23 | 638.56M | ||
GUD.CA | KNIGHT THERAPEUTICS INC | 118 | 586.75M | ||
DHT-U.CA | DRI HEALTHCARE TRUST | 3.8 | 464.56M | ||
ACB.CA | AURORA CANNABIS INC | 29.04 | 366.46M | ||
WEED.CA | CANOPY GROWTH CORP | N/A | 358.67M | ||
CPH.CA | CIPHER PHARMACEUTICALS INC | 19.38 | 317.56M | ||
HITI.CA | HIGH TIDE INC | N/A | 267.91M | ||
OGI.CA | ORGANIGRAM GLOBAL INC | N/A | 214.05M | ||
NGEN.CA | NERVGEN PHARMA CORP | N/A | 209.27M |
Indiva Ltd. engages in producing derivative products and the cultivation of cannabis. The company is headquartered in Ottawa, Ontario. The firm is engaged in producing and selling cannabis products, including dried flower, extract, and edible products. The company focuses on the production and processing of edible and extract cannabis products as well as packaging of edibles and extracts. Its brands include Pearls by Gron, Bhang Chocolate, Indiva Doppio Sandwich Cookies, Indiva 1432 Chocolate, and No Future Gummies and Vapes, as well as other Indiva branded extracts. Its products include edibles and capsules. Its edibles include Vanilla Double -Stuffed Chocolate Cookie, Fudge Double-Stuffed Chocolate Cookie, and Golden Vanilla Double Stuffed Cookie. The company sells its cannabis products to consumers in the recreational market in the provinces of Ontario, British Columbia, Alberta, Quebec, Nova Scotia, Saskatchewan, Manitoba, New Brunswick, Prince Edward Island, Newfound.
INDIVA LTD
333 Preston Street, Suite 710
Ottawa ONTARIO K1S 1N4 CA
CEO: Carmine Marotta
Employees: 142
Company Website: https://indiva.ca/
Phone: 16138838541
The current stock price of NDVA.CA is 0.03 CAD. The price decreased by -14.29% in the last trading session.
The exchange symbol of INDIVA LTD is NDVA and it is listed on the TSX Venture Exchange exchange.
NDVA.CA stock is listed on the TSX Venture Exchange exchange.
5 analysts have analysed NDVA.CA and the average price target is 0.15 CAD. This implies a price increase of 410% is expected in the next year compared to the current price of 0.03. Check the INDIVA LTD stock analysts ratings, price target forecast and up-and down grades for more detailed information.
INDIVA LTD (NDVA.CA) has a market capitalization of 5.86M CAD. This makes NDVA.CA a Nano Cap stock.
INDIVA LTD (NDVA.CA) currently has 142 employees.
INDIVA LTD (NDVA.CA) has a resistance level at 0.06. Check the full technical report for a detailed analysis of NDVA.CA support and resistance levels.
The Revenue of INDIVA LTD (NDVA.CA) is expected to grow by 15.86% in the next year. Check the estimates tab for more information on the NDVA.CA EPS, Sales, EBIT and EBITDA future analyst estimates.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
NDVA.CA does not pay a dividend.
INDIVA LTD (NDVA.CA) will report earnings on 2024-08-27.
INDIVA LTD (NDVA.CA) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.03).
ChartMill assigns a fundamental rating of 2 / 10 to NDVA.CA. NDVA.CA has a bad profitability rating. Also its financial health evaluation is rather negative.
Over the last trailing twelve months NDVA.CA reported a non-GAAP Earnings per Share(EPS) of -0.03. The EPS increased by 62.5% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | N/A | ||
ROA | -11.73% | ||
ROE | N/A | ||
Debt/Equity | N/A |
ChartMill assigns a Buy % Consensus number of 80% to NDVA.CA. The Buy consensus is the average rating of analysts ratings from 5 analysts.
For the next year, analysts expect an EPS growth of 100% and a revenue growth 15.86% for NDVA.CA